Announced Thu, 2 Jul · 09:39 IST
Promoter Sachin Patel to acquire up to 0.50 percent stake via inter-se transfer
GUJTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.7%1-day move
₹396.90
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-2.7-3.5-4.8-7.5-6.0-3.5-9.5———
Up moveDown movePending
AI summary
Sachin D. Patel, a promoter of Gujarat Themis Biosyn Limited, proposes to acquire up to 5,25,000 equity shares (about 0.50 percent of capital) from Pharmaceutical Business Group (India) Limited at Rs. 395.75 per share (up to Rs. 20 Crores), between July 8-14, 2026. This is an inter-se transfer among promoters, exempt from open offer under Regulation 10(1)(a)(ii). Post-acquisition, Patel's stake rises from 2.29 percent to 2.77 percent. The 60-day VWAMP was Rs. 376.60.
Likely market impact
Inter-se promoter transfer, no open offer triggered. Neutral for minority shareholders; indicates promoter group consolidation.